osimertinib
astrazeneca
['lcsm,(-blcsm)', 'osimertinib', 'nsclc', 'elios', 'sclc']
elios: a multicentre, molecular
profiling study of patients with
egfr-mutant advanced nsclc
treated with 1l osimertinib. reminder: challenging to obtain post-pd biopsies (only 39% with full ngs data available) #lcsm #esmo22 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm